Background: The rates of morbidity and mortality associated with lung absce
ss are still significant despite the introduction of antibiotic treatments.
The aim of this work was to identify the factors that predict a poor outco
me for patients with lung abscess.
Methods: We retrospectively reviewed the records and the roentgenographic f
iles of adult patients with lung abscess who were hospitalized from 1980 to
1986 at the Hadassah University Hospital, in Jerusalem, Israel.
Results: The study population comprised 75 patients, and the mean age was 5
2 years old (range, 12 to 89 years), The mean (+/-SD) hospitalization durat
ion was 25.7 +/- 21.5 days (range, 5 to 94 days). Fifteen patients (20%) su
ccumbed to the infection. The patients who died had more predisposing facto
rs (+/-SD), such as pneumonia, neoplasm, and altered consciousness, than th
ose who survived, respectively: 2.73 +/- 1.4 vs 1.9 +/- 1.3 (p < 0.03), The
patients with anemia on admission (hemoglobin levels of < 10 g/dL) had a h
igher mortality rate than those with higher hemoglobin levels, respectively
: 58.3 vs 12.9% (p = 0.0008). A higher mortality rate was also associated w
ith infection by Pseudomonas aeruginosa (83%), Staphylococcus aureus (50%),
and Klebsiella pneumoniae (44%). The patients who died had larger abscess
volumes (+/-SD) than those who survived (233 +/- 99 vs 157 +/- 33 mL), alth
ough it did not reach statistical significance, The diameter of the abscess
correlated with the hospitalization time (r = 0.5; p < 0.001).
Conclusion: High rates of morbidity and mortality are associated with lung
abscess despite appropriate antibiotic therapy and better supportive care.
In patients with several predisposing factors, such as a large abscess size
and a right-lower-lobe location, the prognosis was worse, The patients inf
ected with S aureus, K pneumoniae, and particularly P aeruginosa had an omi
nous prognosis. As the prognosis for lung abscess has not improved sufficie
ntly since the introduction of antibiotics, other modalities should be cons
idered for patients with poor prognostic signs.